<html>
 <body>
  <div class="col-md-12" id="content" style="">
   <div class="hidden" data-drupal-messages-fallback="">
   </div>
   <div class="widget block" id="block-medsites-page-title">
    <h1>
     <span property="schema:name">
      AIDS Defining Conditions
     </span>
    </h1>
   </div>
   <div class="widget block" id="block-medsites-content">
    <article about="/commodorecompendium/aids-defining-conditions" data-history-node-id="2561" role="article" typeof="schema:WebPage">
     <div>
      <div class="field field--name-body field--type-text-with-summary field--label-hidden field__item" property="schema:text">
       <div class="WordSection1">
        <div style="border-bottom:solid windowtext 1.0pt; border-top:solid windowtext 1.0pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
         <p style="border:none; padding:0in">
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <b>
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 AIDS Defining Clinical Conditions – Rebecca Choudhury
                </span>
               </span>
              </b>
             </span>
            </span>
           </span>
          </span>
         </p>
        </div>
        <p style="list-style-type:none">
         <span style="page:WordSection1">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               <span style="color:black">
                AIDS is defined by HIV infection with concurrent absolute CD4 count <200, CD4 percentage <14%, or one of the following conditions, predominately opportunistic infections and HIV associated malignancies
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <p style="margin-bottom:1px; margin-left:25px; text-indent:-9.35pt">
        </p>
        <p style="margin-bottom:1px; margin-left:25px; text-indent:-9.35pt">
        </p>
        <p>
         <span style="page:WordSection1">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <b>
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                Neurologic
               </span>
              </span>
             </b>
             <b>
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 /Ophthalmologic
                </span>
               </span>
              </span>
             </b>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul>
         <li style="list-style-type:none">
          <ul>
           <li style="list-style-type:none">
            <ul>
             <li style="list-style-type:none">
              <ul style="list-style-type:circle">
               <li style="list-style-type:none">
                <ul>
                 <li style="list-style-type:none">
                 </li>
                </ul>
               </li>
              </ul>
             </li>
            </ul>
           </li>
          </ul>
         </li>
        </ul>
        <p>
         <span style="page:WordSection1">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="background:white">
               <span style="font-family:Palatino">
                <span style="color:black">
                 CNS
                </span>
               </span>
              </span>
             </span>
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               <span style="color:black">
                toxoplasmosis
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul style="list-style-type:circle">
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Presentation: Variable, depending on disease burden/location, may include AMS, headache, seizure, ataxia, and focal neurologic deficits, +/- fever and flu-like symptoms
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Evaluation: MRI w/Ring-enhancing lesions on brain imaging (
                  <i>
                   Note
                  </i>
                  : can appear similar to CNS lymphoma), serum Toxoplasma IgG/IgM and (ideally) CSF Toxoplasma PCR. Brain biopsy may be indicated if diagnostic uncertainty.
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Management: Pyrimethamine, sulfadiazine, and leucovorin is the preferred regimen, discuss dosing with pharmacy. Alternative regimens: clindamycin, Bactrim, atovaquone, and/or azithromycin.
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
        </ul>
        <p style="margin-right:48px">
        </p>
        <ul>
         <li style="list-style-type:none">
          <ul>
           <li style="list-style-type:none">
            <ul>
             <li style="list-style-type:none">
              <ul style="list-style-type:circle">
               <li style="list-style-type:none">
                <ul>
                 <li style="list-style-type:none">
                 </li>
                </ul>
               </li>
              </ul>
             </li>
            </ul>
           </li>
          </ul>
         </li>
        </ul>
        <p>
         <span style="page:WordSection1">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="background:white">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Progressive multifocal leukoencephalopathy (PML)
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul style="list-style-type:circle">
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Presentation: chronic (weeks to months), progressive neurologic dysfunction, particularly incoordination
                 </span>
                </span>
               </span>
              </span>
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  and other motor dysfunction, aphasia, sometimes cognitive impairment and personality changes
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Evaluation:  MRI brain w/patchy areas of demyelination in the subcortical white matter; location is variable, but p
                 </span>
                </span>
               </span>
              </span>
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  arietal, occipital, and cerebellar involvement are common. JC virus PCR from CSF. Brain biopsy (uncommonly done)
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Management: Initiation of ART may slow/stop progression. Fatal if HIV goes untreated.
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
        </ul>
        <p style="margin-right:48px; margin-left:37px">
        </p>
        <ul>
         <li style="list-style-type:none">
          <ul>
           <li style="list-style-type:none">
            <ul>
             <li style="list-style-type:none">
              <ul style="list-style-type:circle">
               <li style="list-style-type:none">
                <ul>
                 <li style="list-style-type:none">
                 </li>
                </ul>
               </li>
              </ul>
             </li>
            </ul>
           </li>
          </ul>
         </li>
        </ul>
        <p>
         <span style="page:WordSection1">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="background:white">
               <span style="font-family:Palatino">
                <span style="color:black">
                 HIV-related encephalopathy
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul style="list-style-type:circle">
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Presentation: Similar to other progressive dementias, with short term memory loss followed by
                 </span>
                </span>
               </span>
              </span>
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  worsening global cognitive dysfunction, motor deficits, sometimes seizures in late stages
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Evaluation: MRI w/diffuse cerebral atrophy and/or demyelinating lesions similar to PML. CSF w/elevated protein +/- lymphocytic pleocytosis, with no alternative cause. Send HIV RNA from the CSF, usually + in HIV encephalopathy
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
        </ul>
        <p style="margin-left:37px">
        </p>
        <ul>
         <li style="list-style-type:none">
          <ul>
           <li style="list-style-type:none">
            <ul>
             <li style="list-style-type:none">
              <ul style="list-style-type:circle">
               <li style="list-style-type:none">
                <ul>
                 <li style="list-style-type:none">
                 </li>
                </ul>
               </li>
              </ul>
             </li>
            </ul>
           </li>
          </ul>
         </li>
        </ul>
        <p>
         <span style="page:WordSection1">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="background:white">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Cryptococcal meningitis
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul style="list-style-type:circle">
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Presentation: Subacute to chronically worsening HA and fevers; meningismus and photophobia may be present but are often absent; rarely, focal neurologic deficits
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Evaluation: LP to check opening pressure and can send serum and CSF Cryptococcus Ag. Brain imaging may be non-diagnostic
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Treatment: Induction therapy with amphotericin and flucytosine x14 days (at least), with repeat LP close to end of
                 </span>
                </span>
               </span>
              </span>
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  induction to confirm CSF inflammation is improving and fungal culture is negative.
                 </span>
                </span>
               </span>
              </span>
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Maintenance therapy consists of high dose fluconazole for at least 8 weeks. Pts may require serial LP to manage ICP
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Delay ART for several weeks after start of treatment to avoid risk of IRIS.
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
        </ul>
       </div>
       <p>
       </p>
       <div class="WordSection2">
        <ul>
         <li style="list-style-type:none">
          <ul>
           <li style="list-style-type:none">
            <ul>
             <li style="list-style-type:none">
              <ul style="list-style-type:circle">
               <li style="list-style-type:none">
                <ul>
                 <li style="list-style-type:none">
                 </li>
                </ul>
               </li>
              </ul>
             </li>
            </ul>
           </li>
          </ul>
         </li>
        </ul>
        <p>
         <span style="page:WordSection2">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="background:white">
               <span style="font-family:Palatino">
                <span style="color:black">
                 CMV retinitis (with vision loss)
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul style="list-style-type:circle">
         <li>
          <span style="page:WordSection2">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Presentation: Blurry vision, focal blind spots, visual field deficits, or scotomas and floaters. Typically begins unilateral, though often progresses to bilateral involvement.
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection2">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Evaluation: Always consult ophtho if you suspect it! Hemorrhagic retinitis, “tomato soup and milk” appearance on dilated exam. May cause complete retinal detachment. Check CMV pcr serum (or vitreous)
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection2">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Management:  PO valgancyclovir (+intravitreous ganciclovir or foscarnet in severe disease). If not on ART, must delay ART for at least 2 weeks after start of CMV retinitis treatment to prevent immune recovery uveitis
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
        </ul>
        <p style="margin-bottom:1px; margin-left:25px; text-indent:-9.35pt">
        </p>
        <p style="margin-bottom:1px; margin-left:25px; text-indent:-9.35pt">
        </p>
        <p>
         <span style="page:WordSection2">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <b>
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                Pulmonary
               </span>
              </span>
             </b>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul>
         <li style="list-style-type:none">
          <ul>
           <li style="list-style-type:none">
            <ul>
             <li style="list-style-type:none">
              <ul style="list-style-type:circle">
               <li style="list-style-type:none">
                <ul>
                 <li style="list-style-type:none">
                 </li>
                </ul>
               </li>
              </ul>
             </li>
            </ul>
           </li>
          </ul>
         </li>
        </ul>
        <p>
         <span style="page:WordSection2">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="background:white">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Pneumocystis jirovecii pneumonia (PJP)
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul>
         <li>
          <span style="page:WordSection2">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Presentation: fever, shortness of breath, cough (usually non-productive), sometimes night sweats and weight loss. Hypoxia out of proportion to exam.
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection2">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Evaluation: CT chest appearance usually bilateral and diffuse with GGOs and cystic lesions of varying size. Large cysts can rupture, causing pneumothorax.
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul>
           <li>
            <span style="page:WordSection2">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Induced sputum (or bronchoscopy sample) with cytology and GMS stain.
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection2">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Send serum LDH and 1,3-BD-glucan:  should be elevated, but are nonspecific.
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
          </ul>
         </li>
         <li>
          <span style="page:WordSection2">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Management: Bactrim is the preferred treatment; PO is preferable as Bactrim is 100% bioavailable. **If patient is hypoxic, need to consider of adding steroids, can measure A-a gradient. Alternative regimens may include primaquine + clindamycin or IV (NOT inhaled) pentamidine.
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
        </ul>
        <p style="margin-right:48px; margin-left:37px">
        </p>
        <ul>
         <li style="list-style-type:none">
          <ul>
           <li style="list-style-type:none">
            <ul>
             <li style="list-style-type:none">
              <ul style="list-style-type:circle">
               <li style="list-style-type:none">
                <ul>
                 <li style="list-style-type:none">
                 </li>
                </ul>
               </li>
              </ul>
             </li>
            </ul>
           </li>
          </ul>
         </li>
        </ul>
        <p>
         <span style="page:WordSection2">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="background:white">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Pulmonary tuberculosis
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul style="list-style-type:circle">
         <li>
          <span style="page:WordSection2">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Presentation: With low CD4, can have upper lobe cavities but also atypical radiographic pattern, including a normal-appearing CXR. Have a high degree of suspicion in any patient with advanced HIV and respiratory complaints.
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection2">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Evaluation: TB skin tests and IGRAs have a high false negative rate in advanced HIV. At VUMC, any pt with HIV and respiratory complaints must be placed on airborne until TB ruleout- 3 sputum mycobacterial cultures collected at least 8 hours apart. If concentrated smear is negative x3, TB is unlikely (though have to follow up final culture to be sure).
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection2">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Management: RIPE therapy is the standard initial treatment, with adjustment if needed for drug resistance or contraindications
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
        </ul>
        <p style="margin-right:48px; margin-left:37px">
        </p>
        <ul>
         <li style="list-style-type:none">
          <ul>
           <li style="list-style-type:none">
            <ul>
             <li style="list-style-type:none">
              <ul style="list-style-type:circle">
               <li style="list-style-type:none">
                <ul>
                 <li style="list-style-type:none">
                 </li>
                </ul>
               </li>
              </ul>
             </li>
            </ul>
           </li>
          </ul>
         </li>
        </ul>
        <p>
         <span style="page:WordSection2">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="background:white">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Herpes simplex tracheobronchitis and/or pneumonitis/pneumonia
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul style="list-style-type:circle">
         <li>
          <span style="page:WordSection2">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Evaluation: bronchoscopy with positive HSV PCR from BAL +/- lung biopsy. (Usually associated with HSV-1)
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection2">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Management:  agent and duration not well defined for bronchopulmonary disease; depending on severity of presentation, likely IV acyclovir to start followed by transition to PO antiviral once evidence of clinical improvement, for a total of 10-14 days.
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
        </ul>
        <p style="margin-bottom:1px; margin-left:25px; text-indent:-9.35pt">
        </p>
        <ul>
         <li style="list-style-type:none">
          <ul>
           <li style="list-style-type:none">
            <ul>
             <li style="list-style-type:none">
              <ul>
               <li style="list-style-type:none">
                <ul>
                 <li style="list-style-type:none">
                 </li>
                </ul>
               </li>
              </ul>
             </li>
            </ul>
           </li>
          </ul>
         </li>
        </ul>
        <p>
         <span style="page:WordSection2">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="background:white">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Recurrent pneumonia NOS
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <p style="margin-left:25px">
         <span style="page:WordSection2">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="background:white">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Histoplasmosis, cryptococcosis, coccidiomycosis, and non-TB mycobacterial infections (including MAC) limited to the pulmonary system are not AIDs defining illnesses, though pts with advanced HIV and other severely immunosuppressed states are at higher risk.
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
       </div>
       <p>
       </p>
       <p>
       </p>
       <div class="WordSection3">
        <p>
         <span style="page:WordSection3">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <b>
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                Gastrointestinal
               </span>
              </span>
             </b>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul>
         <li style="list-style-type:none">
          <ul>
           <li style="list-style-type:none">
            <ul>
             <li style="list-style-type:none">
              <ul style="list-style-type:circle">
               <li style="list-style-type:none">
                <ul>
                 <li style="list-style-type:none">
                 </li>
                </ul>
               </li>
              </ul>
             </li>
            </ul>
           </li>
          </ul>
         </li>
        </ul>
        <p>
         <span style="page:WordSection3">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="background:white">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Esophageal candidiasis
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul style="list-style-type:circle">
         <li>
          <span style="page:WordSection3">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Presentation: Dysphagia, odynophagia or both. Concurrent oropharyngeal candidiasis (“thrush’) is common but not universal.
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection3">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Evaluation: Typically presumptive. Treatment is the test; start fluconazole and consider EGD if symptoms do not improve after several days (in which case candidiasis may be severe, or it might not be the cause)
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection3">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Management: Fluconazole; nystatin is ineffective, especially in the severely immunocompromised
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
        </ul>
        <p style="margin-bottom:1px; margin-left:25px; text-indent:-9.35pt">
        </p>
        <ul>
         <li style="list-style-type:none">
          <ul>
           <li style="list-style-type:none">
            <ul>
             <li style="list-style-type:none">
              <ul style="list-style-type:circle">
               <li style="list-style-type:none">
                <ul>
                 <li style="list-style-type:none">
                 </li>
                </ul>
               </li>
              </ul>
             </li>
            </ul>
           </li>
          </ul>
         </li>
        </ul>
        <p>
         <span style="page:WordSection3">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="background:white">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Herpes simplex esophagitis
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul style="list-style-type:circle">
         <li>
          <span style="page:WordSection3">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Evaluation: EGD shows diffuse ulcerations throughout the esophagus; in severe disease ulcers may coalesce into dark patches, “black esophagus.” Esophageal biopsy is definitive, but can infer based on EGD appearance and serum studies.
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection3">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Management: Similar to other mucocutaneous infections, consider IV acyclovir at first and transition to PO once clinically improved
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
        </ul>
        <p style="margin-bottom:1px; margin-left:25px; text-indent:-9.35pt">
        </p>
        <ul>
         <li style="list-style-type:none">
          <ul>
           <li style="list-style-type:none">
            <ul>
             <li style="list-style-type:none">
              <ul style="list-style-type:circle">
               <li style="list-style-type:none">
                <ul>
                 <li style="list-style-type:none">
                 </li>
                </ul>
               </li>
              </ul>
             </li>
            </ul>
           </li>
          </ul>
         </li>
        </ul>
        <p>
         <span style="page:WordSection3">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="background:white">
               <span style="font-family:Palatino">
                <span style="color:black">
                 CMV esophagitis/enteritis/colitis
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul style="list-style-type:circle">
         <li>
          <span style="page:WordSection3">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Presentation: GI bleeding (colitis) or dysphagia and odynophagia (esophagitis)
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection3">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Evaluation: serum CMV PCR, consult GI for consideration of EGD/colonoscopy
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection3">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Management: (val)ganciclovir, foscarnet if ganciclovir resistance or contraindication
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
        </ul>
        <p style="margin-bottom:1px; margin-left:25px; text-indent:-9.35pt">
        </p>
        <ul>
         <li style="list-style-type:none">
          <ul>
           <li style="list-style-type:none">
            <ul>
             <li style="list-style-type:none">
              <ul style="list-style-type:circle">
               <li style="list-style-type:none">
                <ul>
                 <li style="list-style-type:none">
                 </li>
                </ul>
               </li>
              </ul>
             </li>
            </ul>
           </li>
          </ul>
         </li>
        </ul>
        <p>
         <span style="page:WordSection3">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="background:white">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Chronic (>1 mo) intestinal isosporiasis
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul style="list-style-type:circle">
         <li>
          <span style="page:WordSection3">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Evaluation: Stool ova/parasite can capture Iospora belli (new name Cystoisospora belli), may need serial analysis due to intermittent shedding. Oocysts may also be seen on duodenal biopsy.
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection3">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Management: Bactrim; pyrimethamine + leucovorin if Bactrim is contraindicated
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul>
           <li style="list-style-type:none">
           </li>
          </ul>
         </li>
        </ul>
        <p>
         <span style="page:WordSection3">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="background:white">
               <span style="font-family:Palatino">
                <span style="color:black">
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <p>
         <span style="page:WordSection3">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="background:white">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Chronic intestinal cryptosporidiosis
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul style="list-style-type:circle">
         <li>
          <span style="page:WordSection3">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Presentation: Diarrhea; may infect respiratory tract, causing nonproductive cough
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection3">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Evaluation: on GiPP or Cryptosporidium Ag
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection3">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Management: Early initiation or optimization of ART; Monotherapy with nitazoxanide is preferred; raising CD4 count >100 is necessary to cure infection
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
        </ul>
        <p style="margin-bottom:1px; margin-left:25px; text-indent:-9.35pt">
        </p>
        <ul>
         <li style="list-style-type:none">
          <ul>
           <li style="list-style-type:none">
            <ul>
             <li style="list-style-type:none">
              <ul style="list-style-type:circle">
               <li style="list-style-type:none">
                <ul>
                 <li style="list-style-type:none">
                 </li>
                </ul>
               </li>
              </ul>
             </li>
            </ul>
           </li>
          </ul>
         </li>
        </ul>
        <p>
         <span style="page:WordSection3">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="background:white">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Recurrent salmonella septicemia
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul style="list-style-type:circle">
         <li>
          <span style="page:WordSection3">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Generally sensitive to fluoroquinolones, but if not clinically improving as expected you can request sensitivities from the microbiology lab.
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
        </ul>
        <p style="margin-bottom:1px; margin-left:25px; text-indent:-9.35pt">
        </p>
       </div>
       <p>
       </p>
       <p>
        <span style="font-size:11pt">
         <span style="line-height:normal">
          <span style="font-family:Calibri,sans-serif">
           <b>
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              Neoplastic
             </span>
            </span>
           </b>
          </span>
         </span>
        </span>
       </p>
       <ul>
        <li style="list-style-type:none">
         <ul>
          <li style="list-style-type:none">
           <ul>
            <li style="list-style-type:none">
             <ul>
              <li style="list-style-type:none">
               <ul>
                <li style="list-style-type:none">
                </li>
               </ul>
              </li>
             </ul>
            </li>
           </ul>
          </li>
         </ul>
        </li>
       </ul>
       <p>
        <span style="font-size:11pt">
         <span style="line-height:normal">
          <span style="font-family:Calibri,sans-serif">
           <span style="font-size:12.0pt">
            <span style="background:white">
             <span style="font-family:Palatino">
              <span style="color:black">
               Non-Hodgkin’s lymphoma - Burkitt’s, immunoblastic (subset of DLBCL), and 1º CNS
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </span>
       </p>
       <p style="margin-left:25px">
       </p>
       <ul>
        <li style="list-style-type:none">
         <ul>
          <li style="list-style-type:none">
           <ul>
            <li style="list-style-type:none">
             <ul style="list-style-type:circle">
              <li style="list-style-type:none">
               <ul>
                <li style="list-style-type:none">
                </li>
               </ul>
              </li>
             </ul>
            </li>
           </ul>
          </li>
         </ul>
        </li>
       </ul>
       <p>
        <span style="font-size:11pt">
         <span style="line-height:normal">
          <span style="font-family:Calibri,sans-serif">
           <span style="font-size:12.0pt">
            <span style="background:white">
             <span style="font-family:Palatino">
              <span style="color:black">
               Kaposi’s sarcoma
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </span>
       </p>
       <ul style="list-style-type:circle">
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                Presentation: Distinctive mucocutaneous lesions, usually raised, papular, violaceous or darkly colored, non-tender and non-pruritic. Can also involve the visceral organs (esp lungs and GI tract) and deep lymphatic system.
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                Evaluation: clinical, tissue biopsy for staging, HHV-8 serum PCR.
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                Management: Limited mucocutaneous disease may resolve with initiation/optimization of ART, but widespread or resistant disease may require additional local therapies (ex radiation) or systemic chemo
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                Bacillary angiomatosis (caused by Bartonella) may present similarly, but can be distinguished from KS on biopsy. It is neither a cancer nor an AIDS defining clinical condition, and is usually treated with doxycycline.
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
       </ul>
       <p style="margin-right:48px; margin-left:37px">
       </p>
       <ul>
        <li style="list-style-type:none">
         <ul>
          <li style="list-style-type:none">
           <ul>
            <li style="list-style-type:none">
             <ul style="list-style-type:circle">
              <li style="list-style-type:none">
               <ul>
                <li style="list-style-type:none">
                </li>
               </ul>
              </li>
             </ul>
            </li>
           </ul>
          </li>
         </ul>
        </li>
       </ul>
       <p>
        <span style="font-size:11pt">
         <span style="line-height:normal">
          <span style="font-family:Calibri,sans-serif">
           <span style="font-size:12.0pt">
            <span style="background:white">
             <span style="font-family:Palatino">
              <span style="color:black">
               Cervical cancer
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </span>
       </p>
       <ul style="list-style-type:circle">
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                Presentation, diagnosis, and treatment are essentially the same as in HIV-negative patients, but incidence is higher and disease progression is often more rapid
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
       </ul>
       <p style="margin-bottom:1px; margin-left:25px; text-indent:-9.35pt">
       </p>
       <p style="margin-bottom:1px; margin-left:25px; text-indent:-9.35pt">
       </p>
       <p>
        <span style="font-size:11pt">
         <span style="line-height:normal">
          <span style="font-family:Calibri,sans-serif">
           <b>
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              Multisystem/Miscellaneous
             </span>
            </span>
           </b>
          </span>
         </span>
        </span>
       </p>
       <ul>
        <li style="list-style-type:none">
         <ul>
          <li style="list-style-type:none">
           <ul>
            <li style="list-style-type:none">
             <ul style="list-style-type:circle">
              <li style="list-style-type:none">
               <ul>
                <li style="list-style-type:none">
                </li>
               </ul>
              </li>
             </ul>
            </li>
           </ul>
          </li>
         </ul>
        </li>
       </ul>
       <p>
        <span style="font-size:11pt">
         <span style="line-height:normal">
          <span style="font-family:Calibri,sans-serif">
           <span style="font-size:12.0pt">
            <span style="background:white">
             <span style="font-family:Palatino">
              <span style="color:black">
               Extrapulmonary or disseminated Mycobacterial infection (TB and non-TB)
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </span>
       </p>
       <ul style="list-style-type:circle">
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                TB can go everywhere; some notable extrapulmonary sites include lymph nodes (e.g., scrofula), bones and joints (e.g., Pott’s disease of the spine), pleura and pericardium, GU tract, and CNS. Dx can come from tissue culture and sometimes MTB PCR for more rapid detection (needs ID approval).
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                TB-IRIS may be severe (esp with high infection burden) and hard to distinguish from TB treatment failure; can also be seen in adequately treated TB (provoked by the presence of dead bacteria) and undiagnosed latent TB.
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                Disseminated MAC is usually diagnosed with AFB blood culture (only 1 positive needed). Think about it in patients with uncontrolled HIV and severe immunosuppression (esp CD4 <50), with unintentional weight loss, chronic diarrhea and/or dyspnea, and evidence of GI malabsorption or with bone marrow suppression
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
       </ul>
       <p style="margin-right:48px">
       </p>
       <ul>
        <li style="list-style-type:none">
         <ul>
          <li style="list-style-type:none">
           <ul>
            <li style="list-style-type:none">
             <ul style="list-style-type:circle">
              <li style="list-style-type:none">
               <ul>
                <li style="list-style-type:none">
                </li>
               </ul>
              </li>
             </ul>
            </li>
           </ul>
          </li>
         </ul>
        </li>
       </ul>
       <p>
        <span style="font-size:11pt">
         <span style="line-height:normal">
          <span style="font-family:Calibri,sans-serif">
           <span style="font-size:12.0pt">
            <span style="background:white">
             <span style="font-family:Palatino">
              <span style="color:black">
               Extrapulmonary or disseminated Histoplasmosis, Cryptococcocosis, and Coccidiodomycosis
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </span>
       </p>
       <ul style="list-style-type:circle">
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                Can be difficult to distinguish based on clinical presentation and imaging alone. Diagnosed by culture and/or antigen testing depending on the organism and site of infection, and diagnosis may be supported by serologic studies.
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                Initial treatment of choice: liposomal amphotericin B in almost all cases
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
       </ul>
       <p style="margin-right:48px; margin-left:25px">
       </p>
       <ul>
        <li style="list-style-type:none">
         <ul>
          <li style="list-style-type:none">
           <ul>
            <li style="list-style-type:none">
             <ul style="list-style-type:circle">
              <li style="list-style-type:none">
               <ul>
                <li style="list-style-type:none">
                </li>
               </ul>
              </li>
             </ul>
            </li>
           </ul>
          </li>
         </ul>
        </li>
       </ul>
       <p>
        <span style="font-size:11pt">
         <span style="line-height:normal">
          <span style="font-family:Calibri,sans-serif">
           <span style="font-size:12.0pt">
            <span style="background:white">
             <span style="font-family:Palatino">
              <span style="color:black">
               Chronic mucocutaneous HSV
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </span>
       </p>
       <ul style="list-style-type:circle">
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                Defined as mucocutaneous lesions present for >1 month, can be present at any site
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
       </ul>
      </div>
     </div>
    </article>
   </div>
  </div>
 </body>
</html>